The technology development system of Puyang Hongtianwei Pharmaceutical Co., Ltd.

The company's Enterprise Technology Center has 45 employees, accounting for 15 of the company's total employees, including 2 with senior professional titles, 15 with intermediate professional titles, and 20 with junior professional titles, all of whom have a college degree or above. It has five sets of high-performance liquid chromatographs from Waters Company and TSP Company of the United States, two antibiotic potency measuring instruments, two biochemical incubators and mold incubators, and a -80°C strain storage refrigerator. The entire R&D equipment is among the best in the industry. Leading position.

At the beginning of its establishment, the company attached great importance to the enterprise development strategy guided by science and technology. In terms of research and development, it used investment as a guarantee and cooperation as a means, and hired Dr. Zheng Yinghua, who has made great achievements in the field of biopharmaceuticals. He is the technical director of the company, and has a group of doctoral-level, researcher-level, and professor-level experts distributed in national key scientific research institutes and national key laboratories; it continues to strengthen its R&D capabilities and invests more than 8% of its sales in R&D each year, and has successively and Beijing Institute of Biomedicine, China Agricultural University, East China University of Science and Technology, Shenyang Pharmaceutical University, and Wuhan Branch of the Chinese Academy of Sciences have established a solid cooperative development relationship. We have successively developed one national second-class new veterinary drug, two national Torch Plan high-tech products, one national key new product, three high-tech products of Henan Province, implemented one Ministry of Science and Technology Trade Development Project, and the high-tech industrialization of Henan Province One key project.

Gradually established a research and development system with its own characteristics, and has certain technological transformation capabilities, basically realizing a virtuous research and development cycle of producing one generation, reserve one generation, and developing one generation, ensuring the rationality of the company's product structure and the ability to withstand market risks.